Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Greggio

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Neurobiology of Disease|June 6, 2006
Kinase activity is required for the toxic effects of mutant LRRK2/dardarinElisa Greggio, Shushant Jain, Ann Kingsbury, et al.
Glia|October 12, 2020
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytesAlice Filippini, Veronica Mutti, Gaia Faustini, et al.
Journal of Neurochemistry|September 17, 2015
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brainLaura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.
Frontiers in Molecular Neuroscience|March 16, 2018
The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1Maria Perez Carrion, Francesca Pischedda, Alice Biosa, et al.
NPJ Parkinson'S Disease|March 25, 2023
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's diseaseAnna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
Cell Death & Disease|October 17, 2024
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific mannerLucia Iannotta, Rachel Fasiczka, Giulia Favetta, et al.
Cells|March 25, 2022
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, RespectivelyAntoine Marchand, Alessia Sarchione, Panagiotis S Athanasopoulos, et al.
The Biochemical Journal|May 14, 2026
Regulation between LRRK2 and PP2A signaling in cellular models of Parkinsons diseasePanagiotis S Athanasopoulos, Anna Memou, Franz Y Ho, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axonsChuyu Chen, Qianzi He, Giulia Tombesi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2014
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseAlexandria Beilina, Iakov N Rudenko, Alice Kaganovich, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Neurobiology of Disease|June 6, 2006
Kinase activity is required for the toxic effects of mutant LRRK2/dardarinElisa Greggio, Shushant Jain, Ann Kingsbury, et al.
Glia|October 12, 2020
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytesAlice Filippini, Veronica Mutti, Gaia Faustini, et al.
Journal of Neurochemistry|September 17, 2015
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brainLaura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.
Frontiers in Molecular Neuroscience|March 16, 2018
The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1Maria Perez Carrion, Francesca Pischedda, Alice Biosa, et al.
NPJ Parkinson'S Disease|March 25, 2023
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's diseaseAnna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
Cell Death & Disease|October 17, 2024
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific mannerLucia Iannotta, Rachel Fasiczka, Giulia Favetta, et al.
Cells|March 25, 2022
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, RespectivelyAntoine Marchand, Alessia Sarchione, Panagiotis S Athanasopoulos, et al.
The Biochemical Journal|May 14, 2026
Regulation between LRRK2 and PP2A signaling in cellular models of Parkinsons diseasePanagiotis S Athanasopoulos, Anna Memou, Franz Y Ho, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axonsChuyu Chen, Qianzi He, Giulia Tombesi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2014
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseAlexandria Beilina, Iakov N Rudenko, Alice Kaganovich, et al.
Pageof 10